Callan Family Office’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.4M Sell
110,646
-9,942
-8% -$1.12M 0.26% 79
2025
Q4
$15.1M Buy
120,588
+27,924
+30% +$3.56M 0.32% 54
2025
Q3
$12.4M Sell
92,664
-5,499
-6% -$722K 0.4% 49
2025
Q2
$13.4M Buy
98,163
+39,649
+68% +$5.23M 0.42% 48
2025
Q1
$7.76M Sell
58,514
-7,560
-11% -$962K 0.58% 30
2024
Q4
$7.47M Buy
66,074
+60,855
+1,166% +$7.03M 0.48% 39
2024
Q3
$595K Buy
5,219
+1,223
+31% +$134K 0.1% 96
2024
Q2
$415K Buy
3,996
+1,489
+59% +$158K 0.08% 99
2024
Q1
$285K Buy
2,507
+399
+19% +$45.7K 0.07% 78
2023
Q4
$232K Buy
+2,108
New +$211K 0.06% 92
2023
Q3
Sell
-2,630
Closed -$287K 88
2023
Q2
$287K Buy
2,630
+159
+6% +$16.9K 0.08% 88
2023
Q1
$250K Buy
+2,471
New +$261K 0.06% 144

Other funds holding ABT

Callan Family Office's ABT Position: Q1 2026 in Review

Callan Family Office reduced its Abbott (ABT) stake by 8.2% in Q1 2026, selling an estimated $1.12M and leaving 110,646 shares worth $11.4M. The position accounts for 0.26% of the portfolio, ranked #79.

Callan Family Office first reported a position in ABT in Q1 2023 and has held it in 12 quarters since. The position peaked at $15.1M in Q4 2025. 3,086 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Callan Family Office held 110,646 shares of Abbott worth $11.4M as of Q1 2026.
  • Callan Family Office sold 9,942 Abbott shares in Q1 2026, an estimated $1.12M.
  • Abbott made up 0.26% of Callan Family Office's portfolio in Q1 2026, its #79 holding.
  • Callan Family Office first reported a position in Abbott in Q1 2023 and has held it in 12 quarters since.
  • Callan Family Office's Abbott position peaked at $15.1M in Q4 2025.
  • 3,086 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.